Medtronic (MDT) Depreciation and Depletion (2024 - 2026)

Medtronic (MDT) has 3 years of Depreciation and Depletion data on file, last reported at $308.0 million in Q2 2026.

• For the quarter ending Q2 2026, Depreciation and Depletion fell 4.35% year-over-year to $308.0 million; the trailing twelve-month figure through Apr 2026 stood at $1.2 billion (up 7.91% YoY), and the FY2026 full-year result was $1.2 billion, up 7.82% from the prior year.
• Depreciation and Depletion was little changed at $308.0 million in Q2 2026, from $308.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $322.0 million in Q2 2025 to a low of $248.0 million in Q3 2024.
• A 3-year average of $285.9 million and a median of $285.5 million in 2025 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion grew 16.53% in 2025 and dropped 4.35% in 2026, its largest moves.
• Tracing MDT's Depreciation and Depletion over 3 years: stood at $262.0 million in 2024, then gained by 7.63% to $282.0 million in 2025, then climbed by 9.22% to $308.0 million in 2026.
• Business Quant data shows MDT's Depreciation and Depletion at $308.0 million in Q2 2026, $308.0 million in Q1 2026, and $282.0 million in Q4 2025.